Kahn Swick & Foti's Investigation into iRhythm Technologies
Kahn Swick & Foti, LLC (KSF) is continuing its investigation into iRhythm Technologies, Inc. (NASDAQ: IRTC), focusing on the company's officers and directors.
Recent Developments at iRhythm Technologies
The company recently disclosed serious issues flagged by the FDA. These include a Warning Letter regarding regulatory compliance associated with the Zio AT System due to quality control deficiencies. Such issues could pose significant risks to patients, particularly about heart conditions.
Class Action Lawsuit Against iRhythm
Following this alarming revelation, a securities class action lawsuit was filed against iRhythm and its executives for allegedly failing to disclose crucial facts during the class period. The court has allowed this case to continue, denying the company's motion to dismiss.
Focus of the Investigation
KSF is concentrating on whether the executives of iRhythm have violated their fiduciary duties towards shareholders, or if they have breached any state or federal laws. The dedicated team at KSF encourages anyone with pertinent information to reach out.
Get Involved with KSF
If you are a long-term investor in iRhythm and have concerns or information related to the ongoing investigation, feel free to reach out to KSF. They are offering a no-obligation consultation to discuss your rights and options.
About Kahn Swick & Foti, LLC
KSF is recognized as one of the leading securities litigation law firms in the United States. With a team that includes former Attorney General Charles C. Foti, Jr., the firm has a proven history of advocating for investors who face losses due to corporate fraud or other misconduct. They represent both individual investors and institutional stakeholders, showcasing their commitment to securing recoveries for their clients.
Contact Information for KSF
If you have any questions or would like more information, contact Lewis Kahn, Managing Partner at KSF. They have a presence in multiple states and continue to support investors nationwide.
Frequently Asked Questions
What is the current focus of Kahn Swick & Foti's investigation?
KSF is investigating potential breaches of fiduciary duties by iRhythm's executives and whether they violated any laws.
What issues did the FDA raise concerning iRhythm Technologies?
The FDA raised concerns about compliance issues linked to the Zio AT System that could pose risks to patients.
What led to the securities class action lawsuit against iRhythm?
The lawsuit was initiated due to allegations that iRhythm failed to disclose critical information, which misled investors.
How can I contact KSF for more information?
You can call toll-free at 1-833-938-0905 or reach out via email to discuss your legal rights.
What services does Kahn Swick & Foti provide?
KSF specializes in securities litigation and represents investors seeking recoveries from corporate malpractice.
